These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32888140)

  • 1. Correlation of circulating or disseminated tumor cells with the Oncotype DX Recurrence Score.
    Singh P; Tevis SE; Hall CS; Meas S; Hwang RF; Lucci A
    Breast Cancer Res Treat; 2020 Dec; 184(3):683-687. PubMed ID: 32888140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and correlation of risk recurrence in early breast cancer assessed by Oncotype DX
    Aktas B; Bankfalvi A; Heubner M; Kimmig R; Kasimir-Bauer S
    Mol Clin Oncol; 2013 Nov; 1(6):1049-1054. PubMed ID: 24649291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score.
    Hartkopf AD; Wallwiener M; Kommoss S; Taran FA; Brucker SY
    Breast Cancer Res Treat; 2016 Feb; 156(1):91-5. PubMed ID: 26911294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
    Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
    Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and Predictive Value of Circulating and Disseminated Tumor Cells in Breast Cancer: A National Cancer Database (NCDB) Analysis.
    Bilani N; Elson L; Liang H; Elimimian EB; Arteta-Bulos R; Nahleh Z
    Technol Cancer Res Treat; 2020; 19():1533033820980107. PubMed ID: 33287661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients.
    Hartkopf AD; Wallwiener M; Hahn M; Fehm TN; Brucker SY; Taran FA
    Cancer Res Treat; 2016 Jan; 48(1):115-24. PubMed ID: 25687853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
    Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
    BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for the presence of tumor cells in bone marrow and peripheral blood in breast cancer patients.
    Cabinakova M; Mikulova V; Malickova K; Vrana D; Pavlista D; Petruzelka L; Zima T; Tesarova P
    Neoplasma; 2015; 62(2):259-68. PubMed ID: 25591591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
    Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
    Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive lobular carcinoma predicts micrometastasis in breast cancer.
    Gainer SM; Lodhi AK; Bhattacharyya A; Krishnamurthy S; Kuerer HM; Lucci A
    J Surg Res; 2012 Sep; 177(1):93-6. PubMed ID: 22482764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
    Lee SH; Ha S; An HJ; Lee JS; Han W; Im SA; Ryu HS; Kim WH; Chang JM; Cho N; Moon WK; Cheon GJ
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1574-84. PubMed ID: 27209424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
    Fehm T; Hoffmann O; Aktas B; Becker S; Solomayer EF; Wallwiener D; Kimmig R; Kasimir-Bauer S
    Breast Cancer Res; 2009; 11(4):R59. PubMed ID: 19664291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Oncotype DX recurrence score and dynamic contrast-enhanced MRI features in patients with estrogen receptor-positive HER2-negative invasive breast cancer.
    Kim HJ; Choi WJ; Kim HH; Cha JH; Shin HJ; Chae EY
    Clin Imaging; 2021 Jul; 75():131-137. PubMed ID: 33548871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer.
    Krishnamurthy S; Bischoff F; Ann Mayer J; Wong K; Pham T; Kuerer H; Lodhi A; Bhattacharyya A; Hall C; Lucci A
    Cancer Med; 2013 Apr; 2(2):226-33. PubMed ID: 23634290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal Cancer.
    Konczalla L; Ghadban T; Effenberger KE; Wöstemeier A; Riethdorf S; Uzunoglu FG; Izbicki JR; Pantel K; Bockhorn M; Reeh M
    Ann Surg; 2021 Feb; 273(2):299-305. PubMed ID: 31188197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can features evaluated in the routine pathologic assessment of lymph node-negative estrogen receptor-positive stage I or II invasive breast cancer be used to predict the Oncotype DX recurrence score?
    Auerbach J; Kim M; Fineberg S
    Arch Pathol Lab Med; 2010 Nov; 134(11):1697-701. PubMed ID: 21043825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer.
    Magbanua MJM; Yau C; Wolf DM; Lee JS; Chattopadhyay A; Scott JH; Bowlby-Yoder E; Hwang ES; Alvarado M; Ewing CA; Delson AL; Van't Veer LJ; Esserman L; Park JW
    Clin Cancer Res; 2019 Sep; 25(17):5388-5397. PubMed ID: 31142502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and significance of circulating and disseminated tumour cells in colorectal cancer.
    Steinert G; Schölch S; Koch M; Weitz J
    Langenbecks Arch Surg; 2012 Apr; 397(4):535-42. PubMed ID: 22350614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
    Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
    Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.